IG Confirms Many Recovery Act Criminal Investigations
Client Alert | less than 1 min read | 11.03.11
In what should serve as a warning that use of Recovery Act funds continues to draw close scrutiny from federal watchdogs, in written testimony on November 2 before a House subcommittee, DoE Inspector General Friedman revealed that his office has initiated over 100 criminal investigations involving “various schemes, including the submission of false information [and] claims for unallowable or unauthorized expenses,” under the Recovery Act. He also confirmed that his office has “ongoing and planned reviews” of Recovery Act funding and usage.
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
Client Alert | 4 min read | 04.16.26
ROI Tracking as Mens Rea? Novartis Ruling Reframes AKS Pleading Risk


